CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −350 | $453.51 | $159K | 100 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −100 | $454.81 | $45K | 0 |
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 99,750 | ||
| 2025-10-06 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 17,500 | ||
| 2025-10-06 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $445.24 | $445K | 3,130 |
| 2025-10-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,000 | $451.18 | $1.4M | 130 |
| 2025-10-06 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 210,000 | ||
| 2025-10-03 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $443.63 | $444K | 3,130 |
| 2025-10-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,629 | $445.61 | $726K | 1,501 |
| 2025-10-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,371 | $448.81 | $615K | 130 |
| 2025-10-03 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 214,000 | ||
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,430 | $433.72 | $620K | 46,351 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,828 | $435.22 | $796K | 44,523 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,881 | $436.24 | $821K | 42,642 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,136 | $437.15 | $1.4M | 39,506 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,905 | $438.17 | $835K | 37,601 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −346 | $439.19 | $152K | 37,255 |
Page 195 of 214 · 4,273 trades